Photo by luismmolina/iStock via Getty Images
Without deviation from the norm, progress is not possible.” ― Frank Zappa
Today we take an in-depth look at a small developmental firm whose shares have rocketed up so far in 2021. A full analysis follows below.
Company Overview:
GT Biopharma, Inc. (GTBP) is a Beverley Hills-based biotech concern focused on the development of immuno-therapeutic products with an initial focus on oncology. The company has one asset undergoing evaluation in a Phase 1/2…
Getting To Know GT Biopharma
Share this article
More News

Australia moves to share crypto tax data globally by 2028
October 17, 2026

CoinShares reports $434M crypto fund outflows after hot U.S. CPI
October 17, 2026


Summary: This Week in Crypto W2 Oct 26’
October 17, 2026



Crypto Banking Shift: Deutsche Bank Custody and What’s Next
October 17, 2026